Paper8554983
Oestrogen receptor: a stable phenotype in breast cancer.
Robertson JF. Br J Cancer, 1996. Cited by 123 papers, by iCite.
Cite this record
ConductScience Library. Oestrogen receptor: a stable phenotype in breast cancer. Papers, record 8554983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8554983
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Receptors, Estrogen | Major topic |
| Animals | |
| Humans | |
| Phenotype |
Source PubMed
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2606454 | Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study. | Histopathology | 1989 | https://conductscience.org/library/papers/2606454 | PubMed |
| 2 | 2164337 | Estrogen receptors in ductal carcinoma in situ of breast. | Am Surg | 1990 | https://conductscience.org/library/papers/2164337 | PubMed |
| 3 | 2393857 | Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells. | Cancer Res | 1990 | https://conductscience.org/library/papers/2393857 | PubMed |
| 4 | 2224859 | Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. | Cancer Res | 1990 | https://conductscience.org/library/papers/2224859 | PubMed |
| 5 | 1988075 | Variant human breast tumor estrogen receptor with constitutive transcriptional activity. | Cancer Res | 1991 | https://conductscience.org/library/papers/1988075 | PubMed |
| 6 | 200253 | Reproducibility of measurements of oestrogen-receptor concentration in breast cancer. | Br J Cancer | 1977 | https://conductscience.org/library/papers/200253 | PubMed |
| 7 | 922747 | Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. | Cancer Res | 1977 | https://conductscience.org/library/papers/922747 | PubMed |
| 8 | 631176 | Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer. | Eur J Cancer (1965) | 1978 | https://conductscience.org/library/papers/631176 | PubMed |
| 9 | 698968 | Estrogen receptor assay in primary breast cancer and early recurrence of the disease. | Cancer Res | 1978 | https://conductscience.org/library/papers/698968 | PubMed |
| 10 | 708575 | Oestrogen receptors and the response to endocrine therapy in advanced breast cancer. | Br J Cancer | 1978 | https://conductscience.org/library/papers/708575 | PubMed |
| 11 | 728342 | Inter-site variation of oestrogen receptors in human breast cancers. | Br J Cancer | 1978 | https://conductscience.org/library/papers/728342 | PubMed |
| 12 | 86771 | Oestrogen receptors and prognosis in early breast cancer. | Lancet | 1979 | https://conductscience.org/library/papers/86771 | PubMed |
| 13 | 476576 | Prognostic value of estrogen receptors in primary breast cancer. | Cancer | 1979 | https://conductscience.org/library/papers/476576 | PubMed |
| 14 | 7357496 | Changes in multiple or sequential estrogen receptor determinations in breast cancer. | Cancer | 1980 | https://conductscience.org/library/papers/7357496 | PubMed |
| 15 | 7358078 | Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma. | Eur J Cancer (1965) | 1980 | https://conductscience.org/library/papers/7358078 | PubMed |
| 16 | 7371003 | Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer. | Cancer Res | 1980 | https://conductscience.org/library/papers/7371003 | PubMed |
| 17 | 7214366 | Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer. | Cancer Res | 1981 | https://conductscience.org/library/papers/7214366 | PubMed |
| 18 | 7226005 | Estrogen receptor: a prognostic factor in breast cancer. | Cancer | 1981 | https://conductscience.org/library/papers/7226005 | PubMed |
| 19 | 7235760 | Sampling procedures in estrogen receptor determinations. | Ann Surg | 1981 | https://conductscience.org/library/papers/7235760 | PubMed |
| 20 | 7272932 | Clinical pharmacology of tamoxifen in patients with breast cancer: correlation with clinical data. | Cancer | 1981 | https://conductscience.org/library/papers/7272932 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38281118 | Study of Drug Targets Associated With Oncogenesis and Cancer Cell Survival and the Therapeutic Activity of Engineered Ashwagandha Extract Having Differential Withanolide Constitutions. | Integr Cancer Ther | 2024 | https://conductscience.org/library/papers/38281118 | PubMed |
| 30659843 | Insights into how phosphorylation of estrogen receptor at serine 305 modulates tamoxifen activity in breast cancer. | Mol Cell Endocrinol | 2019 | https://conductscience.org/library/papers/30659843 | PubMed |
| 25925673 | Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial. | J Transl Med | 2015 | https://conductscience.org/library/papers/25925673 | PubMed |
| 24758408 | Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation. | BMC Cancer | 2014 | https://conductscience.org/library/papers/24758408 | PubMed |
| 24449872 | Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24449872 | PubMed |
| 21903739 | Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET. | J Nucl Med | 2011 | https://conductscience.org/library/papers/21903739 | PubMed |
| 21447808 | Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α. | J Natl Cancer Inst | 2011 | https://conductscience.org/library/papers/21447808 | PubMed |
| 20496165 | Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk. | Breast Cancer Res Treat | 2011 | https://conductscience.org/library/papers/20496165 | PubMed |
| 20473330 | Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure. | Oncogene | 2010 | https://conductscience.org/library/papers/20473330 | PubMed |
| 19372579 | Estradiol-induced regression in T47D:A18/PKCalpha tumors requires the estrogen receptor and interaction with the extracellular matrix. | Mol Cancer Res | 2009 | https://conductscience.org/library/papers/19372579 | PubMed |
| 17912640 | Femara and the future: tailoring treatment and combination therapies with Femara. | Breast Cancer Res Treat | 2007 | https://conductscience.org/library/papers/17912640 | PubMed |
| 17804714 | Genetic screening reveals an essential role of p27kip1 in restriction of breast cancer progression. | Cancer Res | 2007 | https://conductscience.org/library/papers/17804714 | PubMed |
| 17486454 | Growth factor signalling in endocrine and anti-growth factor resistant breast cancer. | Rev Endocr Metab Disord | 2007 | https://conductscience.org/library/papers/17486454 | PubMed |
| 17160137 | The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17160137 | PubMed |
| 15642172 | Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway. | Breast Cancer Res | 2005 | https://conductscience.org/library/papers/15642172 | PubMed |
| 15536519 | Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene. | J Mol Med (Berl) | 2005 | https://conductscience.org/library/papers/15536519 | PubMed |
| 14973389 | Estrogen receptor alpha in human breast cancer: occurrence and significance. | J Mammary Gland Biol Neoplasia | 2000 | https://conductscience.org/library/papers/14973389 | PubMed |
| 12118371 | Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. | Oncogene | 2002 | https://conductscience.org/library/papers/12118371 | PubMed |
| 12096339 | Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. | Oncogene | 2002 | https://conductscience.org/library/papers/12096339 | PubMed |
| 12013530 | The role of estrogen receptors in breast cancer metastasis. | J Mammary Gland Biol Neoplasia | 2001 | https://conductscience.org/library/papers/12013530 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8554983
GET https://conductscience.org/api/papers/v1/8554983/references?page=2